id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-N-0104-0003,FDA,FDA-1998-N-0104,University of Texas MD Anderson Cancer Center - Nomination,Other,NOM-Nomination,2010-03-17T04:00:00Z,2010,3,2010-03-17T04:00:00Z,,2013-07-27T21:43:31Z,,0,0,090000648058775b
FDA-1998-N-0104-0004,FDA,FDA-1998-N-0104,Nomination from International Academy of Compounding Pharmacists (IACP),Other,NOM-Nomination,2010-03-17T04:00:00Z,2010,3,2010-03-17T04:00:00Z,,2015-01-14T16:43:19Z,,0,0,0900006480587767
FDA-1998-N-0104-0002,FDA,FDA-1998-N-0104,Abbott Laboratories - Nomination,Other,NOM-Nomination,2010-03-17T04:00:00Z,2010,3,2010-03-17T04:00:00Z,,2010-03-17T18:05:16Z,,0,0,0900006480587758
FDA-1998-N-0104-0001,FDA,FDA-1998-N-0104,List of Bulk Drug Substances That May Be Used in Pharmacy Compounding,Proposed Rule,NPR-Notice of Proposed Rule-Making,1999-01-19T05:00:00Z,1999,1,1999-01-19T05:00:00Z,1999-03-24T04:59:59Z,2010-03-17T17:35:01Z,,0,0,09000064805876cd